Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel M Simon

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Nature|April 24, 2024
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicaseKristen A Baltgalvis, Kelsey N Lamb, Kent T Symons, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Covalent inhibitors of the RAS binding domain of PI3Kα impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Science (New York, N.Y.)|October 9, 2025
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Cancer Discovery|December 19, 2025
A covalent allosteric molecular glue suppresses NRF2-dependent cancer growthNilotpal Roy, Tine Wyseure, I-Chung Lo, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Nature|April 24, 2024
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicaseKristen A Baltgalvis, Kelsey N Lamb, Kent T Symons, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Covalent inhibitors of the RAS binding domain of PI3Kα impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Science (New York, N.Y.)|October 9, 2025
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2Joseph E Klebba, Nilotpal Roy, Steffen M Bernard, et al.
Cancer Discovery|December 19, 2025
A covalent allosteric molecular glue suppresses NRF2-dependent cancer growthNilotpal Roy, Tine Wyseure, I-Chung Lo, et al.
Pageof 6